BMJ Group Retina Logo
BMJ Group Retina Logo
Find an expert2024-12-19T09:37:09+00:00

Find an expert

Our panel of editors are available for interview

Filters
Expertise

Professor Stephen Kaye

2024-06-27T15:51:07+00:00Expertise : |

Editor-in-Chief BMJ Open Ophthalmology

Contact

Professor of Ophthalmology, Institute of Life Course and Medical Sciences, University of Liverpool where he leads the research into infections of the eye,  Consultant Ophthalmologist Royal Liverpool University Hospital where he leads the Cornea and Ocular Surface Disease Service, Vice President of The Royal College of Ophthalmologists, Director of The Liverpool Research Eye Biobank, NHS England National lead for Corneal Transplantation, Honorary Professorship, Queens University, Belfast.

Professor Gisli Jenkins

2024-06-27T16:02:50+00:00Expertise : , |

Chair of the Editorial Board for BMJ Open Respiratory Research

Contact

Professor Gisli Jenkins is an NIHR Research Professor and holds the Margaret Turner-Warwick Chair of Thoracic Medicine at Imperial College London, Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins’ research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium.

 

Professor Ronald F. van Vollenhoven

2024-06-27T16:03:26+00:00Expertise : , , |

Editor-in-Chief of Lupus Science & Medicine

Contact

Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.

Professor Hans Kromhout

2024-06-27T15:45:28+00:00Expertise : , , , , |

Editor-in-Chief of Occupational & Environmental Medicine

Contact

Professor Hans Kromhout is an occupational hygiene and epidemiology specialist, based at the Institute for Risk Assessment Sciences at Utrecht University in the Netherlands. Professor Kromhout’s work has covered the health effects of chemical and physical (EMF) agents in the workplace and general environment. He has been the (co-)PI of large international studies in among others the asphalt industry, rubber manufacturing industry, industrial minerals industry, health sector and agriculture and community based studies on cancer, respiratory diseases, neurodegenerative diseases and reproductive health effects.

Dr Ellen Weber

2024-06-27T15:56:11+00:00Expertise : , , , , , |

Editor-in-Chief of Emergency Medicine Journal

Contact

Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.

Professor Ganesan Karthikeyan

2024-06-27T16:24:49+00:00Expertise : , , , , , |

Editor-in-Chief Open Heart

Contact

Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.

Go to Top